Crystalline forms of atorvastatin

Details for Australian Patent Application No. 2002224952 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Szelagiewicz, Martin; Blatter, Fritz; Schoning, Kai-Uwe; Van Der Schaaf, Paul, Adriaan

Agent Spruson & Ferguson

Pub. Number AU-B-2002224952

PCT Pub. Number WO2002/051804

Priority 00811249.2 27.12.00 EP

Filing date 19 December 2001

Wipo publication date 8 July 2002

Acceptance publication date 5 April 2007

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-B-2002224952

26 February 2004 Assignment before Grant

  Ciba Specialty Chemicals Holding Inc. The application has been assigned to Teva Pharmaceutical Industries Ltd. Assignments before Grant, Section 113

5 April 2007 Application Accepted

  Published as AU-B-2002224952

2 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002224953-AN ORAL AND PARENTERAL PHARMACEUTICAL FORMULATION COMPRISING A LOW MOLECULAR WEIGHT THROMBIN INHIBITOR PRODRUG

2002224951-USE OF OXABICYCLO(2.2.1)HEPTADIENE DERIVATIVES AS PESTICIDAL AGENTS